Cargando…

Surgical therapy and next-generation sequencing-based genetic alteration analysis of malignant solitary fibrous tumor of the pleura

BACKGROUND: Solitary fibrous tumor of the pleura (SFTP) is a rare pleural neoplasm arising from mesenchymal cells, accounting for <5% of pleural neoplasms. Approximately 10% of cases of SFTP demonstrate malignant potential, leading to local recurrence after radical surgery and subsequent metastas...

Descripción completa

Detalles Bibliográficos
Autores principales: Song, Zuoqing, Yang, Fan, Zhang, Yingguo, Fan, Ping, Liu, Guowei, Li, Chao, Ding, Wansheng, Zhang, Yulong, Xu, Xiaohong, Ye, Yancheng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6118252/
https://www.ncbi.nlm.nih.gov/pubmed/30214228
http://dx.doi.org/10.2147/OTT.S168045
_version_ 1783351894316417024
author Song, Zuoqing
Yang, Fan
Zhang, Yingguo
Fan, Ping
Liu, Guowei
Li, Chao
Ding, Wansheng
Zhang, Yulong
Xu, Xiaohong
Ye, Yancheng
author_facet Song, Zuoqing
Yang, Fan
Zhang, Yingguo
Fan, Ping
Liu, Guowei
Li, Chao
Ding, Wansheng
Zhang, Yulong
Xu, Xiaohong
Ye, Yancheng
author_sort Song, Zuoqing
collection PubMed
description BACKGROUND: Solitary fibrous tumor of the pleura (SFTP) is a rare pleural neoplasm arising from mesenchymal cells, accounting for <5% of pleural neoplasms. Approximately 10% of cases of SFTP demonstrate malignant potential, leading to local recurrence after radical surgery and subsequent metastasis. METHODS: A large malignant-like mass was found in the left thoracic cavity of a 61-year-old woman. Following radical resection of the mass, the patient was diagnosed with malignant SFTP by histologic and immunohistochemical analyses. In addition, a next-generation sequencing-based mutation test was used to reveal the mutational profile of the tumor. The genetic alteration panel was analyzed with reference to public data on the ClinVar and COSMIC databases, after which the public SFTP data were analyzed for frequency of altered genes. Finally, through overlay of the abovementioned two sets, the genetic alteration accounting for SFTP initiation was anticipated to be identified. RESULTS: In the mutation panel of our malignant SFTP group, kinase insert domain receptor (KDR) and fms-related tyrosine kinase 1 (FLT1) scored high in pathogenesis but had only a medium frequency; the NAB2–STAT6 fusion appeared to be the dominant genetic alteration in public SFTP samples. CONCLUSION: The high frequency of NAB2–STAT6 fusion indicates its prominent role in SFTP, while somatic mutations such as FLT1-R593W and KDR-V297I may also contribute to the malignant angiogenic phenotype. The present study affirmed the heterogeneity of SFTP, and more sophisticated classification methods will be needed to explore its underlying mechanisms. SUMMARY: We believe that improvement in the prognosis of SFTP relies on early diagnosis, margin-free resection, and long-term follow-up. Through genetic analysis, it appears that both NAB2–STAT6 fusion and somatic mutations such as FLT1-R593W and KDR-V297I contribute to SFTP development.
format Online
Article
Text
id pubmed-6118252
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Dove Medical Press
record_format MEDLINE/PubMed
spelling pubmed-61182522018-09-13 Surgical therapy and next-generation sequencing-based genetic alteration analysis of malignant solitary fibrous tumor of the pleura Song, Zuoqing Yang, Fan Zhang, Yingguo Fan, Ping Liu, Guowei Li, Chao Ding, Wansheng Zhang, Yulong Xu, Xiaohong Ye, Yancheng Onco Targets Ther Original Research BACKGROUND: Solitary fibrous tumor of the pleura (SFTP) is a rare pleural neoplasm arising from mesenchymal cells, accounting for <5% of pleural neoplasms. Approximately 10% of cases of SFTP demonstrate malignant potential, leading to local recurrence after radical surgery and subsequent metastasis. METHODS: A large malignant-like mass was found in the left thoracic cavity of a 61-year-old woman. Following radical resection of the mass, the patient was diagnosed with malignant SFTP by histologic and immunohistochemical analyses. In addition, a next-generation sequencing-based mutation test was used to reveal the mutational profile of the tumor. The genetic alteration panel was analyzed with reference to public data on the ClinVar and COSMIC databases, after which the public SFTP data were analyzed for frequency of altered genes. Finally, through overlay of the abovementioned two sets, the genetic alteration accounting for SFTP initiation was anticipated to be identified. RESULTS: In the mutation panel of our malignant SFTP group, kinase insert domain receptor (KDR) and fms-related tyrosine kinase 1 (FLT1) scored high in pathogenesis but had only a medium frequency; the NAB2–STAT6 fusion appeared to be the dominant genetic alteration in public SFTP samples. CONCLUSION: The high frequency of NAB2–STAT6 fusion indicates its prominent role in SFTP, while somatic mutations such as FLT1-R593W and KDR-V297I may also contribute to the malignant angiogenic phenotype. The present study affirmed the heterogeneity of SFTP, and more sophisticated classification methods will be needed to explore its underlying mechanisms. SUMMARY: We believe that improvement in the prognosis of SFTP relies on early diagnosis, margin-free resection, and long-term follow-up. Through genetic analysis, it appears that both NAB2–STAT6 fusion and somatic mutations such as FLT1-R593W and KDR-V297I contribute to SFTP development. Dove Medical Press 2018-08-28 /pmc/articles/PMC6118252/ /pubmed/30214228 http://dx.doi.org/10.2147/OTT.S168045 Text en © 2018 Song et al. This work is published and licensed by Dove Medical Press Limited The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed.
spellingShingle Original Research
Song, Zuoqing
Yang, Fan
Zhang, Yingguo
Fan, Ping
Liu, Guowei
Li, Chao
Ding, Wansheng
Zhang, Yulong
Xu, Xiaohong
Ye, Yancheng
Surgical therapy and next-generation sequencing-based genetic alteration analysis of malignant solitary fibrous tumor of the pleura
title Surgical therapy and next-generation sequencing-based genetic alteration analysis of malignant solitary fibrous tumor of the pleura
title_full Surgical therapy and next-generation sequencing-based genetic alteration analysis of malignant solitary fibrous tumor of the pleura
title_fullStr Surgical therapy and next-generation sequencing-based genetic alteration analysis of malignant solitary fibrous tumor of the pleura
title_full_unstemmed Surgical therapy and next-generation sequencing-based genetic alteration analysis of malignant solitary fibrous tumor of the pleura
title_short Surgical therapy and next-generation sequencing-based genetic alteration analysis of malignant solitary fibrous tumor of the pleura
title_sort surgical therapy and next-generation sequencing-based genetic alteration analysis of malignant solitary fibrous tumor of the pleura
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6118252/
https://www.ncbi.nlm.nih.gov/pubmed/30214228
http://dx.doi.org/10.2147/OTT.S168045
work_keys_str_mv AT songzuoqing surgicaltherapyandnextgenerationsequencingbasedgeneticalterationanalysisofmalignantsolitaryfibroustumorofthepleura
AT yangfan surgicaltherapyandnextgenerationsequencingbasedgeneticalterationanalysisofmalignantsolitaryfibroustumorofthepleura
AT zhangyingguo surgicaltherapyandnextgenerationsequencingbasedgeneticalterationanalysisofmalignantsolitaryfibroustumorofthepleura
AT fanping surgicaltherapyandnextgenerationsequencingbasedgeneticalterationanalysisofmalignantsolitaryfibroustumorofthepleura
AT liuguowei surgicaltherapyandnextgenerationsequencingbasedgeneticalterationanalysisofmalignantsolitaryfibroustumorofthepleura
AT lichao surgicaltherapyandnextgenerationsequencingbasedgeneticalterationanalysisofmalignantsolitaryfibroustumorofthepleura
AT dingwansheng surgicaltherapyandnextgenerationsequencingbasedgeneticalterationanalysisofmalignantsolitaryfibroustumorofthepleura
AT zhangyulong surgicaltherapyandnextgenerationsequencingbasedgeneticalterationanalysisofmalignantsolitaryfibroustumorofthepleura
AT xuxiaohong surgicaltherapyandnextgenerationsequencingbasedgeneticalterationanalysisofmalignantsolitaryfibroustumorofthepleura
AT yeyancheng surgicaltherapyandnextgenerationsequencingbasedgeneticalterationanalysisofmalignantsolitaryfibroustumorofthepleura